UPenn Health System expanding into New Jersey

Princeton Healthcare System (PCHS) will join the University of Pennsylvania Health System (UPHS), marking the latter’s first expansion beyond Pennsylvania’s borders.

The deal, approved by University of Pennsylvania trustees Dec. 12, still requires approval from state and federal regulators. If finalized, UPHS would add the 429-bed PCHS, including its flagship University Medical Center of Princeton in Plainsboro, N.J., which was ranked among the top 20 hospitals in the New York City metropolitan region by U.S. News and World Report.

“Affiliating with the University of Pennsylvania Health System represents the best means of assuring that PHCS and its affiliates can continue to fulfill their mission and charitable objectives in the future,” PHCS President and CEO Barry Rabner said in a statement. “When this partnership is finalized, members of our community will  receive enhanced high-quality care right here, close to home, and they will enjoy the added benefit of easier access to the latest medical breakthroughs, clinical trials, cutting-edge technologies and specialized clinical expertise here and elsewhere in the Penn Medicine system.”

The deal would add additional revenue to UPHS’s already robust financials. The system grew to $5.7 billion in revenue for fiscal year 2016, with an operating margin around 7 percent.

PCHS, with its nearly 3,000 staff members and 1,100 physicians, had about $437 million in revenue in fiscal year 2015, thanks to its high rates of privately insured patients.

“PHCS is an impressive organization which plays a crucial role in ensuring the health of New Jersey residents,” said J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of UPHS. “We look forward to many new initiatives as we join together.”

The two systems had signed a letter of intent in July to explore a deal after PCHS spent a year evaluating potential partners. It chose UPHS over 17 other systems. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.